To help alleviate the strain on overwhelmed labs and get testing capacity where it needs to be, Dascena has opened a COVID-19 testing lab in Houston, Texas. Dascena’s lab, which is funded and accelerated by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative, uses state of the art technology and a CLIA validated process to provide high throughput COVID-19 polymerase chain reaction (PCR) diagnostic testing. The lab is currently focused on analyzing samples obtained from a nasopharyngeal swab and is accepting samples from across the United States, offering competitive pricing and a turn-around time of 24 hours upon sample receipt.
Dascena's laboratory has already partnered with, and is performing testing for a variety of groups across the United States, including nursing home and assisted living communities, hospitals and emergency rooms, as well as other regional testing facilities.
Dr. Diane I. Scaduto, Ph.D. leads Dascena’s molecular laboratory team as the Director of Laboratory Operations. Dr. Scaduto brings over a decade of leadership experience in molecular genetics testing. She previously held roles of scientific and laboratory operations leadership at the Houston Forensic Science Center, overseeing a team of forty. Prior to that, she was the Scientific Director of Applied Diagnostics, where she led a team that validated over 70 molecular genetics assays across three platforms. Dr. Scaduto has also served as a molecular biology expert for numerous inspection teams for the College of American Pathologists (CAP). Dr. Scaduto holds a Ph.D. in cell and molecular biology from Baylor School of Medicine and completed post-doctoral training at the MD Anderson Cancer Center.
Dr. Chris Barton, M.D. serves as Dascena’s Director of Clinical Development. Dr. Barton brings over 38 years of clinical operations and diagnostics research and development experience. Dr. Barton joined Dascena from UCSF where he held several academic and clinical leadership positions including Chief of the Emergency Department and Vice-Chair of the Department of Emergency Medicine. Prior to UCSF, Dr. Barton was on the faculty at the University of North Carolina, Chapel Hill. Dr. Barton is a leading infectious disease and emergency medicine researcher and his work have resulted in numerous peer-reviewed publications in leading journals such as the Journal of the American Medical Association (JAMA). Dr. Barton holds an MD from UCSF and completed his residency training at Dartmouth-Hitchcock Medical Center.